ID   OAW42-A
AC   CVCL_W125
DR   Wikidata; Q54931686
RX   PubMed=8100138;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1615 ! OAW42
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=8100138; DOI=10.1016/S0959-8049(05)80291-6;
RA   Redmond A., Moran E., Clynes M.;
RT   "Multiple drug resistance in the human ovarian carcinoma cell line
RT   OAW42-A.";
RL   Eur. J. Cancer 29:1078-1081(1993).
//